Modern histologic imaging platforms coupled with machine learning methods have provided
new opportunities to map the spatial distribution of immune cells in the tumor …

Simple Summary Risk assessment in early breast cancer is critical for clinical decisions, but
defining risk categories poses a significant challenge. The integration of conventional …

Breast cancer is the most prevalent cancer worldwide, affecting both low-and middle-income
countries, with a growing number of cases. In 2024, about 310,720 women in the US are …

Introduction Histological images contain phenotypic information predictive of patient
outcomes. Due to the heavy workload of pathologists, the time-consuming nature of …

Breast cancer is a prevalent malignancy in the present day, particularly affecting women as
one of the most common forms of cancer. A significant portion of patients initially present …

Background Epirubicin/cyclophosphamide (EC) and docetaxel (D) are commonly used in a
sequential regimen in the neoadjuvant treatment of early, high-risk or locally advanced …

Simple Summary TIL scoring has been recommended as a biomarker in routine clinical
practice in breast cancer patients. Currently, the standard of care for early breast cancer is …

Tumor-infiltrating lymphocytes (TILs) are associated with improved survival in patients with
epithelial ovarian cancer. However, the evaluation of TILs has not been applied to routine …

Breast cancer, a widespread and life-threatening disease, necessitates precise diagnostic
tools for improved patient outcomes. Tumor-Infiltrating Lymphocytes (TILs), reflective of the …

Tumor-infiltrating lymphocytes (TILs) and the tumor microenvironment have become
increasingly important in cancer research, and immunotherapy has achieved major …